Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation
Despite prior treatment with no reactivation in 6 months, 32.2% reactivate, 73.9% of which within 3 years. A significant proportion, 39.1%, reactivated without symptoms necessitating regular monitoring in the first 5 years.
Authors
- Jose Carlo M. Artiaga (ORCID: https://orcid.org/0000-0003-4632-7968)
- Sridevi Thottarath
- Swetha Kumar (ORCID: https://orcid.org/0000-0003-4557-9549)
- Shiao Wei Wong (ORCID: https://orcid.org/0000-0003-4318-5984)
- Pankaja Dhoble (ORCID: https://orcid.org/0000-0001-7103-0248)
- Luke Nicholson (ORCID: https://orcid.org/0000-0001-6685-4402)
- Deepthy Menon
Institutions
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Manchester Royal Eye Hospital (GB)
- Philippine General Hospital (PH)
- University of the Philippines Manila (PH)
Publication Details
- Journal
- Clinical and Experimental Ophthalmology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1111/ceo.14444
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69